“…As previously noted (24,45), some features of MVNT align more with a malformation of cortical development or dysplasia than a neoplasm, supported by evidence in this current study. This includes (i) the lack of any growth on serial MRI or reported regrowth, even following incomplete resection, (ii) no overt increase in cellularity or conspicuous mitotic activity, (iii) lack of expansive or infiltrative growth patterns with nodules 'sitting' in an undisturbed laminar cortex, (iv) comparable localizations in deep cortex/subcortical region in reported cases, (v) retained expression of immature, developmentally regulated proteins as SOX2, TBR1, OTX1, KCC1 and GFAPo, (vi) absence of any of the known genetic abnormalities of LEATs following NGS, including BRAF V600E, MYB and FGFR1 mutations (15,25,42,44,47,50) and (vii) NGS in the present study showing recurring synonymous SNPs in SMO and DEPDC5 in common with cortical dysplasia (FCD IIB) and NPRL3 SNPs noted frequently in MNVT and FCD but not other glioneuronal tumors. Copy number variations in SMO a receptor in the Shh pathway have been recently shown in hypothalamic hamartoma associated with gelastic seizures (22) and DEPDC5 and NPRL3 mutations reported in FCDII (5,56).…”